Our strategy is to identify, prepare and commercialise our portfolio candidates for faster market entry and early revenue generation for the Company, ensuring continued development of our technologies matched with returns to shareholders.
Identify cutting edge technologies in dermatology, oncology and acquire the IP
Prepare technologies to valuation realisation
Commercialise through a partner, securing a deal that aims to prioritise further development, marketing and early revenue to Incanthera